EPIDEMIOLOGICAL PROFILE AND NURSING ASSESSMENTS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION TREATED WITH GLICOPROTEIN INHIBITORS IIB IIIA IN SANATORIO ALLENDE.
DOI:
https://doi.org/10.59843/2618-3692.v18.n32.22729Keywords:
Acutemyocardialinfarction, nursing, epidemiology, angioplasty, AgrastatAbstract
Summary: Acutemyocardialinfarction (AMI) represents the third cause ofmorbidity and mortality in the country. Having information about the reality of this entity in the institution is of the utmost importance as a starting point for the development of prevention policies, as well as improving the treatment, care and quality of patientcare. Objective: To determine the epidemiological profile of the population that is being treated with Tirofiban during acute myocardialinfarction (AMI). Materials and methods: A retrospective study of the medical records of patients whoreceived treatment for a cutemyocardialinfarction. A total of 76 clinical histories we restudied, in which the medical evolutions, nursing assessments and the record soft the Hemodynamics Service were analyzed. The search was directed to compare and analyze antecedents and report son the evolution of the patient documented in nursing records. Results:The average age of the patients was 57 ± 11 years. Hypertension (60.52%) and smoking (48.68%) were the most prevalent modifiable factors; the reperfusion rate was higherthan 94% of the patients, of which 26.78% had primary coronary transluminal angioplasty (CTPA) with Tirofiban as adjuvant, with a prehospital delay of 162 minutes and an 83-minute gateto-balloon time. The main intrahospital complications were arterial hypotension and minorhemorrhages, mostly associated with arterial punctures. Conclusions: Of the patients subjected to CTPA with Tirofiban as coadjuvant, the male sex predominated, and hypertension and dyslipidemia were found asthemain risk factors. The delays in the treatment are important and there are points to improve, they were detected in 46.06% of the cases and are linked in part to the ignorance of the population, this is a modifiable point that can be improved with awareness and education measures on the importance of going to a health center immediately when symptoms related to AMI appear. Hemorrhages and hypotension were the most frequent complications, constant monitoring and the rapid action of nursing were fundamental to treat and normalize them.
Downloads
References
1. Pérez GE, Costabel JP, González N, Zaidel E. Infarto agudo de miocardio en la R. Argentina:Registro CONAREC XVII. Rev Argent Cardiol
[Internet]. 2013 [cited 2017 Jun 16];85(5):390–9.Availablefrom: https://www.sac.org.ar/wpcontent/uploads/2014/04/3462.pdf
2. Tajer CD, Charask A, Castillo Costa Y, Antonietti L, Geronazzo R, Allín J, et al. Consenso de Infaro Agudo de Miocardio con Elevación del segmento
ST. Rev Argentina Cadiología [Internet]. 2015 [cited 2017 Jun 16];83(4). Availablefrom: https://www.sac.org.ar/wpcontent/uploads/2015/10/consenso-IAM-con-elevacionST-2015.pdf
3. Fabelo AR. Reconocimiento de las arritmias por el personal de enfermería en la fase aguda del infarto cardíaco. Medicentro Electrónica [Internet]. 2015[cited 2017 Jun 16];19(3):206–8. Availablefrom:
http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30432015000300018
4. O’Gara PT, Kushner FG, Ascheim DD,Casey DE, Chung MK, de Lemos JA, et al. 2013 ACC/AHA Guidelineforthe Management of ST-ElevationMyocardialInfarction. Circulation [Internet]. 2013 [cited 2017 Jun 16];127(4):78–140. Availablefrom: http://circ.ahajournals.org/
content/127/4/e362
5. Gagliardi JA, Charask A, Perna E, D’Imperio H,Bono J, Castillo Costa Y, et al. NationalSurveyof ST-SegmentElevationAcuteMyocardialInfarction in
Argentina (ARGEN-IAM-ST). Argentine J Cardiol[Internet]. 2017 [cited 2017 Jun 16];84(6):548–57.Availablefrom: http://ppct.caicyt.gov.ar/index.php/rac/article/view/9508/pdf_1
6. Paolasso E, Bono J, Castro R, Conci E, Fernandez Cid G, Luciardi H, et al. GUíAS de manejo de los síndromes coronarios agudos con elevación
del segmento ST. Revusta Fed Argentina Cardiol [Internet]. 2012 [cited 2017 Jun 16];41(3):218. Availablefrom: http://www.fac.org.ar/1/
revista/12v41n3/exclusivo_online/exclusivo_01/exclusivo_online.pdf
7. Acuña Valerio J, Abundes Velasco A. Estadodel arte de la trombólisis intracoronaria. Rev Mex[Internet]. 2016 [cited 2017 Jun 16];27(1):41–6.
Availablefrom: http://www.medigraphic.com/pdfs/cardio/h-2016/hs161e.pdf.
8. Gabriel Steg P, James SK, Atar D, Badano LP. ESC Guidelines for the management of acutemyocardial infarction in patients present in gwith ST-segment elevation. Eur Heart J [Internet]. 2012 [cited 2017 Jun [6];33(20):2569–619. Availablefrom: http://www.cmr-guide.com/Contents/Acute_MI_ESC_Guidelines.pdf
9. Balmori Marin BL, Martínez Rodríguez I, Suárez Yanes E, Calero Pérez Y. Caracterización clínicoepidemiológica del infarto agudo del miocardio
trombolizado en la unidad de cuidados intensivos de adultos. Clinical-epidemiologist characterization of the trombolized acutemyocardialinfarction in the Adult Intensive Careunit. MEDICIEGO
Ignacio Martínez Rodríguez Ezequiel Suárez Yanes [Internet]. 2013 [cited 2017 Jun 16];19(11). Availablefrom: http://www.medigraphic.com/pdfs/
mediciego/mdc-2013/mdcs131h.pdf
10. Medina MS, Riquenes YO, Pérez LP, Cruz ZG, Fernández RC. Guía de práctica clínica sobre el tratamiento trombolítico del infarto agudo del
miocardio con elevación del segmento ST en la primera asistencia médica. Rev Electrónica Dr Zoilo E Mar Vidaurreta [Internet]. 2015 Nov 18
[cited 2017 Jun 16];38(8). Availablefrom: http://revzoilomarinello.sld.cu/index.php/zmv/article/view/489/pdf_137
11. Coll Muñoz Y, Valladares Carvajal F de J, Gonzáles Rodríguez C. Infarto agudo de miocardio. Actualización de la Guía de Práctica Clínica. RevFinlay [Internet]. 2011 [cited2017 Jun 16];6(2):170–90. Availablefrom:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S2221-24342016000200010
12. Cornellat DM, Simarro JVC, Gil BG. Actualizacion de los cuidados en laadministracion de fibrinoliticos. Enfermería Glob [Internet]. 2006
[cited 2017 Jun 16];5(2). Availablefrom: http://revistas.um.es/eglobal/article/view/366/334
13. Piombo A, Salzberg S, Lowenberg T, Grasso C. Epidemiología del infarto agudo de miocardio en los hospitales públicos de la Capital Federal. Rev Argent [Internet]. 1999[cited 2017 Jun 16];67(2):201–7.
Availablefrom: https://www.sac.org.ar/wpcontent/uploads/2015/03/PDFs201503/309.pdf
14. Piskorz D, Quaglino MB, Pigozzi F, Vitelleschi. Importancia de las variables no hemodinámicas en el desarrollo de hipertrofia ventricular izquierda en hipertensión. Rev Fed Argentina Cardiol.2010;39(4):288–93.
15. Escobar Serrano L, Mariño RY. Factores de riesgo de infarto agudo del miocardio en pacientes con diagnóstico de hipertensión arterial [Internet].Vol. 20, MULTIMED Revista Médica Granma.
Departamento Editorial, Centro Provincial de
Informacio?n de Ciencias Me?dicas de Granma; 2017
[cited 2017 Jun 16]. 129-143 p. Availablefrom:
http://www.revmultimed.sld.cu/index.php/mtm/article/view/393/626
16. Alvarez J, Migliaro G, Leiva G, FernándezRecalde ML, Donato B, Baglioni P, et al. Angioplastia primaria en diabéticos vs. no diabéticos con infarto agudo de miocardio: predictores de mortalidad. ArchCardiol México [Internet]. 2016 [cited 2017 Jun16];86(1):11–7. Availablefrom: http://linkinghub.elsevier.com/retrieve/pii/S1405994015000981
17. ANMAT. Vademecum Nacional de Medicamentos. Prospecto de AGRASTAT [Internet]. Buenos Aires: ANMAT, Ministerio de Salud de la Nación. [cited 2017 Jun]. Availablefro: https://servicios.pami.org.ar/vademecum/v i e w s / c o n s u l t a P u b l i c a / p r e s e n t a c i o n . z u l
Downloads
Published
Issue
Section
License
Copyright (c) 2018 Sanatorio Allende
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Those authors who have published with this journal, accept the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
